Annual CFF
$136.40 M
+$135.58 M+16635.58%
December 31, 2023
Summary
- As of February 8, 2025, PRLD annual cash flow from financing activities is $136.40 million, with the most recent change of +$135.58 million (+16635.58%) on December 31, 2023.
- During the last 3 years, PRLD annual CFF has fallen by -$109.83 million (-44.61%).
- PRLD annual CFF is now -44.61% below its all-time high of $246.23 million, reached on December 31, 2020.
Performance
PRLD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$131.00 K
-$190.00 K-322.03%
September 30, 2024
Summary
- As of February 8, 2025, PRLD quarterly cash flow from financing activities is -$131.00 thousand, with the most recent change of -$190.00 thousand (-322.03%) on September 30, 2024.
- Over the past year, PRLD quarterly CFF has dropped by -$117.00 thousand (-835.71%).
- PRLD quarterly CFF is now -100.06% below its all-time high of $217.75 million, reached on September 30, 2020.
Performance
PRLD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$25.15 M
-$219.00 K-0.86%
September 30, 2024
Summary
- As of February 8, 2025, PRLD TTM cash flow from financing activities is $25.15 million, with the most recent change of -$219.00 thousand (-0.86%) on September 30, 2024.
- Over the past year, PRLD TTM CFF has dropped by -$111.50 million (-81.59%).
- PRLD TTM CFF is now -93.36% below its all-time high of $378.68 million, reached on June 30, 2021.
Performance
PRLD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRLD Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -835.7% | -81.6% |
| 3 y3 years | -44.6% | -184.5% | +2986.0% |
| 5 y5 years | +660.4% | -184.5% | +2986.0% |
PRLD Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.3% | >+9999.0% | -100.1% | +51.3% | -84.8% | +6299.8% |
| 5 y | 5-year | -44.6% | >+9999.0% | -100.1% | +90.0% | -93.4% | +6299.8% |
| alltime | all time | -44.6% | >+9999.0% | -100.1% | +90.0% | -93.4% | +6299.8% |
Prelude Therapeutics Incorporated Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$131.00 K(-322.0%) | $25.15 M(-0.9%) |
| Jun 2024 | - | $59.00 K(-521.4%) | $25.37 M(-81.4%) |
| Mar 2024 | - | -$14.00 K(-100.1%) | $136.65 M(+0.2%) |
| Dec 2023 | $136.40 M(>+9900.0%) | $25.24 M(>+9900.0%) | $136.40 M(+22.5%) |
| Sep 2023 | - | $88.00 K(-99.9%) | $111.31 M(-0.1%) |
| Jun 2023 | - | $111.34 M(<-9900.0%) | $111.37 M(>+9900.0%) |
| Mar 2023 | - | -$269.00 K(-273.5%) | $393.00 K(-51.8%) |
| Dec 2022 | $815.00 K | $155.00 K(+4.7%) | $815.00 K(-68.8%) |
| Sep 2022 | - | $148.00 K(-58.8%) | $2.61 M(-17.7%) |
| Jun 2022 | - | $359.00 K(+134.6%) | $3.18 M(-1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $153.00 K(-92.2%) | $3.24 M(-98.0%) |
| Dec 2021 | $164.90 M(-33.0%) | $1.95 M(+174.8%) | $164.90 M(+2.0%) |
| Sep 2021 | - | $711.00 K(+68.5%) | $161.64 M(-57.3%) |
| Jun 2021 | - | $422.00 K(-99.7%) | $378.68 M(+0.1%) |
| Mar 2021 | - | $161.81 M(<-9900.0%) | $378.19 M(+53.6%) |
| Dec 2020 | $246.23 M(+728.2%) | -$1.31 M(-100.6%) | $246.23 M(-0.5%) |
| Sep 2020 | - | $217.75 M(<-9900.0%) | $247.53 M(+731.2%) |
| Jun 2020 | - | -$65.00 K(-100.2%) | $29.78 M(-0.2%) |
| Mar 2020 | - | $29.85 M | $29.85 M |
| Dec 2019 | $29.73 M(+65.7%) | - | - |
| Dec 2018 | $17.94 M | - | - |
FAQ
- What is Prelude Therapeutics Incorporated annual cash flow from financing activities?
- What is the all time high annual CFF for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated annual CFF year-on-year change?
- What is Prelude Therapeutics Incorporated quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated quarterly CFF year-on-year change?
- What is Prelude Therapeutics Incorporated TTM cash flow from financing activities?
- What is the all time high TTM CFF for Prelude Therapeutics Incorporated?
- What is Prelude Therapeutics Incorporated TTM CFF year-on-year change?
What is Prelude Therapeutics Incorporated annual cash flow from financing activities?
The current annual CFF of PRLD is $136.40 M
What is the all time high annual CFF for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high annual cash flow from financing activities is $246.23 M
What is Prelude Therapeutics Incorporated annual CFF year-on-year change?
Over the past year, PRLD annual cash flow from financing activities has changed by +$135.58 M (+16635.58%)
What is Prelude Therapeutics Incorporated quarterly cash flow from financing activities?
The current quarterly CFF of PRLD is -$131.00 K
What is the all time high quarterly CFF for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high quarterly cash flow from financing activities is $217.75 M
What is Prelude Therapeutics Incorporated quarterly CFF year-on-year change?
Over the past year, PRLD quarterly cash flow from financing activities has changed by -$117.00 K (-835.71%)
What is Prelude Therapeutics Incorporated TTM cash flow from financing activities?
The current TTM CFF of PRLD is $25.15 M
What is the all time high TTM CFF for Prelude Therapeutics Incorporated?
Prelude Therapeutics Incorporated all-time high TTM cash flow from financing activities is $378.68 M
What is Prelude Therapeutics Incorporated TTM CFF year-on-year change?
Over the past year, PRLD TTM cash flow from financing activities has changed by -$111.50 M (-81.59%)